von Tobias Borgers | Aug. 16, 2021 | Frewitt
CRISPR technology, a gene editing tool that can be used to splice and alter the DNA inside a cell, has for years been hailed as the future of genetic disease medicine. However, despite its vast therapeutic potential, the technology does have its limitations; while...
von Tobias Borgers | Aug. 16, 2021 | Fette
Investition in Biotechnologie BASF baut World-Scale-Produktion für bakterielle Enzyme aus 04.05.2021Redakteur: Alexander StarkMit einer Investition in den Campus Kundl/Schaftenau in Österreich will BASF seine Position auf dem Markt für Enzyme und Biotechnologie weiter...
von Tobias Borgers | Aug. 16, 2021 | Frewitt
Big data and artificial intelligence (AI) have the potential to improve clinical efficiency and drug discovery by decoding large data sets into actionable insights. Over the next two years, big data and AI will be the most disruptive influences in the pharma sector...
von Tobias Borgers | Aug. 16, 2021 | Boehringer
Introduction Chronic obstructive pulmonary disease (COPD) is a preventable and modifiable condition characterized by irreversible or poorly reversible airflow obstruction and persistent respiratory symptoms due to airway and/or alveolar abnormalities. The disease is...
von Tobias Borgers | Aug. 10, 2021 | Tablet Coating
KandJMarketResearch.com fügt einen neuen Bericht zu „Marktforschung für zuckerbeschichtete Tabletten: Globaler Status und Prognose nach Geografie, Typ und Anwendung (2017-2027)“ hinzu, der neue Forschungsergebnisse mit Details zu den Auswirkungen von...
